Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging
Authors:
- Carlo PapponeCPCarlo Pappone
- Vincenzo SantinelliVSVincenzo Santinelli
- Valerio MecarocciVMValerio Mecarocci
- Giuseppe CiconteGCGiuseppe Ciconte
- Francesco MangusoFMFrancesco Manguso
- Francesco SturlaFSFrancesco Sturla
- Emanuele MicaglioEmanuele Micaglio
- Luigi AnastasiaLALuigi Anastasia
- Silvia PicaSPSilvia Pica
- Antonia CamporealeACAntonia Camporeale
- 1 November 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (11) , 1024-1036
Abstract
Background: Brugada syndrome (BrS) is considered a purely electrical disease with variable electrical substrates. Variable rates of mechanical abnormalities have been also reported. Whether exists a link between electrical and mechanical abnormalities has never been previously explored. This investigational physiopathological study aimed to determine the relationship between the substrate size/location, as exposed by ajmaline provocation, and the severity of mechanical abnormalities, as assessed by cardiac magnetic resonance in patients with BrS. Methods: Twenty-four consecutive high-risk patients with BrS (mean age, 38±11 years, 17 males), presenting with malignant syncope and documented polymorphic ventricular tachycardia/ventricular fibrillation, and candidate to implantable cardioverter defibrillator implantation, underwent cardiac magnetic resonance and electroanatomic maps. During each examination, ajmaline test (1 mg/kg over 5 minutes) was performed. Cardiac magnetic resonance findings were compared with 24 age, sex, and body surface area-matched controls. In patients with BrS, the correlation between the electrical substrate extent and right ventricular regional mechanical abnormalities before/after ajmaline challenge was analyzed. Results: After ajmaline, patients with BrS showed a reduction of right ventricular (RV) ejection fraction ( P P P P P 2 to 14.2±7.3 cm 2 ( P r =−0.830, P <0.001). In patients with BrS and normal controls, cardiac magnetic resonance detected neither myocardial fibrosis nor RV outflow tract morphological abnormalities. Conclusions: BrS is a dynamic RV electromechanical disease, where functional abnormalities correlate with the maximal extent of the substrate size. These findings open new lights on the physiopathology of the disease. Registration: URL: https://clinicaltrial.gov ; Unique identifier: NCT03524079.Keywords
This publication has 45 references indexed in Scilit:
- SCN5A Mutations in Brugada Syndrome Are Associated with Increased Cardiac Dimensions and Reduced ContractilityPLOS ONE, 2012
- Insights into the location of type I ECG in patients with Brugada syndrome: Correlation of ECG and cardiovascular magnetic resonance imagingHeart Rhythm, 2012
- Evaluation of Brugada syndrome by cardiac magnetic resonanceThe International Journal of Cardiovascular Imaging, 2012
- Right ventricular dysfunction in patients with Brugada-like electrocardiography: a two dimensional strain imaging studyCardiovascular Ultrasound, 2011
- Ionic mechanisms of cellular electrical and mechanical abnormalities in Brugada syndromeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force CriteriaEuropean Heart Journal, 2010
- Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinationsJournal of Cardiovascular Magnetic Resonance, 2009
- Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocolsJournal of Cardiovascular Magnetic Resonance, 2008
- Cardiac Histological Substrate in Patients With Clinical Phenotype of Brugada SyndromeCirculation, 2005
- Right Ventricular Fibrosis and Conduction Delay in a Patient With Clinical Signs of Brugada SyndromeCirculation, 2005